PainCareLive

CME Presentations

Abuse-Deterrent Formulations


Presentations


Speakers

  • Jeffrey Gudin, MD

    Jeffrey Gudin, MD

    Jeffrey Gudin, MD

    Director, Pain Management and Palliative Care

    Jeffrey Gudin, MD, is the director of pain management and palliative care at Englewood Hospital and Medical Center in Englewood, New Jersey. His clinical and research focus includes pain management, opioid abuse and potential solutions, and increasing clinician awareness of pain assessment and risk management. A nationally recognized leader in pain management, Dr Gudin is active in teaching and research, and has collaborated with numerous initiatives to enhance responsible prescribing and the safe use of opioid pain medications. He serves as a consultant to state medical boards on challenging cases, as well as to industry on novel analgesic products and risk management associated with opioids. Dr. Gudin received his medical degree from Albany Medical College in Albany, New York.
  • Charles E. Argoff, MD

    Charles E. Argoff, MD

    Charles E. Argoff, MD

    Professor of Neurology

    Charles E. Argoff, MD, is professor of neurology at Albany Medical College, and director of the Comprehensive Pain Center at Albany Medical Center in Albany, New York. Dr Argoff specializes in pain management and chronic headaches, and has expertise in several types of pain treatments, including pharmacologic management, interventional pain management and the use of botulinum toxins. He is currently president of the American Academy of Pain Medicine Foundation, the neuropathic pain section co-editor for Pain Medicine, serves on the editorial boards of Applied Neurology, BMC Neurology and Clinical Journal of Pain, and is co-author of Defeat Chronic Pain Now, a book for people with chronic pain. He received his medical degree from Northwestern University Medical School in Chicago, Illinois.

CME Information

Targeting Opioid Misuse: Abuse-Deterrent Formulations in the Management of Acute and Chronic Pain


  

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Summarize the opioid crisis, barriers to the optimal management of pain, and strategies in how to address them
  • Incorporate opioid therapies as appropriate to treat acute and chronic pain, in consideration of the risks and benefits associated with its use
  • Assess the therapeutic rationale of abuse-deterrent formulations in treating acute and chronic pain
  • Distinguish abuse-deterrent formulations and how each formulation is designed to prevent abuse/misuse

Acknowledgement

This activity is supported by an educational grant from Daiichi Sankyo, Inc.

Tuition

Complimentary

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity

Tuesday, March 13, 2018 from 2:00pm – 3:00pm EDT

Enduring Material

The enduring material will be available from March 13, 2018 to March 13, 2019.

Target Audience

This activity is intended for Emergency medicine physicians, medical oncologists, neurologists, primary care physicians including those in family medicine and internal medicine, advanced practice clinicians and nurses, and other clinicians prescribing opioids for traumatic and non-traumatic acute pain, and for non-cancer and cancer-related chronic pain.

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete

Method Of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Facutly

Jeffrey Gudin, MD
Director, Pain Management and Palliative Care
Englewood Hospital and Medical Center

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College

Disclosure of Conflict of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Jeffrey Gudin, MD
Consulting Fees: BDSI, Daiichi, KemPharm, Nektar, Pernix, Quest
Fees for Non-CME/CE Services Received Directly from a Commercial
Interest or their Agents: Collegium, Daiichi, Purdue, Salix

Charles E. Argoff, MD
Royalty: Elsevier, Cambridge Press
Consulting Fees: Amgen, Depomed, Daiichi Sankyo, Egalet, Grüenenthal, Nevro, Pfizer, Purdue, Quest, Teva, Vertex Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Allergan, AstraZeneca, BDSI, Collegium, Depomed, DSI, Jazz
Contracted Research to Institution: Grüenenthal, Vertex
Ownership Interest: Depomed, Pfizer

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Anne Roc, PhD, None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support
For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive or PainCareLive at 877-394-1306 or at Support@PsychiatryCareLive.com..